Cargando…

Clinical impact of HLA class I expression in rectal cancer

PURPOSE: To determine the clinical impact of human leukocyte antigen (HLA) class I expression in irradiated and non-irradiated rectal carcinomas. EXPERIMENTAL DESIGN: Tumor samples in tissue micro array format were collected from 1,135 patients. HLA class I expression was assessed after immunohistoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speetjens, Frank M., de Bruin, Elza C., Morreau, Hans, Zeestraten, Eliane C. M., Putter, Hein, van Krieken, J. Han, van Buren, Maaike M., van Velzen, Monique, Dekker-Ensink, N. Geeske, van de Velde, Cornelis J. H., Kuppen, Peter J. K.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2253649/ https://www.ncbi.nlm.nih.gov/pubmed/17874100 http://dx.doi.org/10.1007/s00262-007-0396-y

Ejemplares similares

Sialyl Lewis X Expression and Lymphatic Microvessel Density in Primary Tumors of Node-negative Colorectal Cancer Patients Predict Disease Recurrence
por: Doekhie, Fania S., et al.
Publicado: (2008)

FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
por: Zeestraten, Eliane C. M., et al.
Publicado: (2011)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
por: Benard, Anne, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer
por: Benard, Anne, et al.
Publicado: (2014)

Biomarkers in precision therapy in colorectal cancer
por: Reimers, Marlies S., et al.
Publicado: (2013)

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Copy number alterations and allelic ratio in relation to recurrence of rectal cancer
por: Goossens-Beumer, Inès J, et al.
Publicado: (2015)

Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
por: Speetjens, Frank M., et al.
Publicado: (2008)

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
por: Derr, Remco S, et al.
Publicado: (2014)

The Prognostic Value of the Apoptosis Pathway in Colorectal Cancer: A Review of the Literature on Biomarkers Identified by Immunohistochemistry
por: Zeestraten, Eliane C.M., et al.
Publicado: (2013)

Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer
por: de Muijnck, Cansu, et al.
Publicado: (2020)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
por: Krijgsman, Daniëlle, et al.
Publicado: (2019)

Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo
por: de Bruin, Elza C., et al.
Publicado: (2007)

The Homeobox Gene MEIS1 Is Methylated in BRAF (p.V600E) Mutated Colon Tumors
por: Dihal, Ashwin A., et al.
Publicado: (2013)

High-resolution analysis of HLA class I alterations in colorectal cancer
por: Dierssen, Jan Willem F, et al.
Publicado: (2006)

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
por: de Kruijf, Esther M, et al.
Publicado: (2012)

Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials
por: van der Hage, Jos A, et al.
Publicado: (2011)

Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients
por: van de Weerd, Simone, et al.
Publicado: (2022)

Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer
por: Benard, A, et al.
Publicado: (2013)

Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles
por: de Bruin, Elza C, et al.
Publicado: (2005)

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021)

Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study
por: Smit, Marloes, et al.
Publicado: (2019)

Surgical Treatment for Unexplained Severe Pain of the Thyroid Gland: Report of Three Cases and Concise Review of the Literature
por: van Schaik, Jan, et al.
Publicado: (2011)

A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
por: van de Water, Ricky B., et al.
Publicado: (2021)

Current and Future Intraoperative Imaging Strategies to Increase Radical Resection Rates in Pancreatic Cancer Surgery
por: Handgraaf, Henricus J. M., et al.
Publicado: (2014)

Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma
por: Tummers, Willemieke S., et al.
Publicado: (2017)

Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells
por: de Geus, Susanna WL, et al.
Publicado: (2017)

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis
por: Frouws, Martine A., et al.
Publicado: (2017)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study
por: Lips, Daniel J, et al.
Publicado: (2011)

Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines
por: Boot, Arnoud, et al.
Publicado: (2017)

Characterization of novel low passage primary and metastatic colorectal cancer cell lines
por: Boot, Arnoud, et al.
Publicado: (2016)

Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value
por: Kranenbarg, E Klein, et al.
Publicado: (2001)

The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
por: Attia, Jiji V. D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_buljtf6fcl81dr18ijh5se3pql